Management tracks: UCB Ventures, GlycoMimetics, Fluidigm

UCB Ventures hired Alicia Irurzun-Lafitte as a partner. She was a principal at M Ventures, the corporate venture fund of Merck KGaA (Xetra:MRK).

GlycoMimetics Inc. (NASDAQ:GLYC) said Chairman Jim Barrett will retire from the board. Board member Tim Pearson will succeed him, effective May 17...